260 related articles for article (PubMed ID: 26233177)
1. A multicenter study to quantify systematic variations and associated uncertainties in source positioning with commonly used HDR afterloaders and ring applicators for the treatment of cervical carcinomas.
Awunor O; Berger D; Kirisits C
Med Phys; 2015 Aug; 42(8):4472-83. PubMed ID: 26233177
[TBL] [Abstract][Full Text] [Related]
2. Direct reconstruction and associated uncertainties of 192Ir source dwell positions in ring applicators using gafchromic film in the treatment planning of HDR brachytherapy cervix patients.
Awunor OA; Dixon B; Walker C
Phys Med Biol; 2013 May; 58(10):3207-25. PubMed ID: 23603854
[TBL] [Abstract][Full Text] [Related]
3. Assessment of a source position checking tool for the quality assurance of transfer tubes used in HDR
Awunor OA
Brachytherapy; 2018; 17(3):628-633. PubMed ID: 29352643
[TBL] [Abstract][Full Text] [Related]
4. Spatial reproducibility of the ring and tandem high-dose rate cervix applicator.
Bahena JH; Martinez A; Yan D; Mele E; Edmunson G; Brown D; Hardy M; Brabbins D; Gustafson G
Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):13-9. PubMed ID: 9588912
[TBL] [Abstract][Full Text] [Related]
5. A multicentre 'end to end' dosimetry audit for cervix HDR brachytherapy treatment.
Palmer AL; Diez P; Gandon L; Wynn-Jones A; Bownes P; Lee C; Aird E; Bidmead M; Lowe G; Bradley D; Nisbet A
Radiother Oncol; 2015 Feb; 114(2):264-71. PubMed ID: 25583568
[TBL] [Abstract][Full Text] [Related]
6. Multihelix rotating shield brachytherapy for cervical cancer.
Dadkhah H; Kim Y; Wu X; Flynn RT
Med Phys; 2015 Nov; 42(11):6579-88. PubMed ID: 26520749
[TBL] [Abstract][Full Text] [Related]
7. The feasibility study and characterization of a two-dimensional diode array in "magic phantom" for high dose rate brachytherapy quality assurance.
Espinoza A; Beeksma B; Petasecca M; Fuduli I; Porumb C; Cutajar D; Corde S; Jackson M; Lerch ML; Rosenfeld AB
Med Phys; 2013 Nov; 40(11):111702. PubMed ID: 24320410
[TBL] [Abstract][Full Text] [Related]
8. A novel system for commissioning brachytherapy applicators: example of a ring applicator.
Fonseca GP; Van den Bosch MR; Voncken R; Podesta M; Verhaegen F
Phys Med Biol; 2017 Oct; 62(21):8360-8375. PubMed ID: 28914613
[TBL] [Abstract][Full Text] [Related]
9. A new approach to measure dwell position inaccuracy in HDR ring applicators - quantification and corrective QA.
Jangda AQ; Hussein S; Rehman Z
J Appl Clin Med Phys; 2010 Sep; 12(1):3355. PubMed ID: 21330984
[TBL] [Abstract][Full Text] [Related]
10. Surface dose characterisation of the Varian Ir-192 HDR conical surface applicator set with a vertically orientated source.
Buchauer K; Henke G; Schiefer H; Plasswilm L
Strahlenther Onkol; 2014 Nov; 190(12):1163-8. PubMed ID: 25081332
[TBL] [Abstract][Full Text] [Related]
11. Commissioning of Varian ring & tandem HDR applicators: reproducibility and interobserver variability of dwell position offsets.
McMahon R; Zhuang T; Steffey BA; Song H; Craciunescu OI
J Appl Clin Med Phys; 2011 Nov; 12(4):3447. PubMed ID: 22089000
[TBL] [Abstract][Full Text] [Related]
12. A multicentre audit of HDR/PDR brachytherapy absolute dosimetry in association with the INTERLACE trial (NCT015662405).
Díez P; Aird EGA; Sander T; Gouldstone CA; Sharpe PHG; Lee CD; Lowe G; Thomas RAS; Simnor T; Bownes P; Bidmead M; Gandon L; Eaton D; Palmer AL
Phys Med Biol; 2017 Nov; 62(23):8832-8849. PubMed ID: 28984277
[TBL] [Abstract][Full Text] [Related]
13. Determination of transit dose profile for a (192)Ir HDR source.
Fonseca GP; Rubo RA; Minamisawa RA; dos Santos GR; Antunes PC; Yoriyaz H
Med Phys; 2013 May; 40(5):051717. PubMed ID: 23635265
[TBL] [Abstract][Full Text] [Related]
14. Improved source path localisation in ring applicators and the clinical impact for gynecological brachytherapy.
Humer I; Kirisits C; Berger D; Trnková P; Pötter R; Nesvacil N
J Contemp Brachytherapy; 2015 Jun; 7(3):239-43. PubMed ID: 26207113
[TBL] [Abstract][Full Text] [Related]
15. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy.
Hellebust TP; Kirisits C; Berger D; Pérez-Calatayud J; De Brabandere M; De Leeuw A; Dumas I; Hudej R; Lowe G; Wills R; Tanderup K;
Radiother Oncol; 2010 Aug; 96(2):153-60. PubMed ID: 20663578
[TBL] [Abstract][Full Text] [Related]
16. Dwell position inaccuracy in the Varian GammaMed HDR ring applicator.
Stern RL; Liu T
J Appl Clin Med Phys; 2010 Sep; 11(4):3158. PubMed ID: 21081871
[TBL] [Abstract][Full Text] [Related]
17. Techniques for and uncertainties of MRI-based reconstruction of titanium tandem and ring brachytherapy applicators.
Malajovich I; Anamalayil S; Dolney OV; Kevin Teo BK; Arscott WT; Taunk NK
Brachytherapy; 2020; 19(5):651-658. PubMed ID: 32624406
[TBL] [Abstract][Full Text] [Related]
18. Problems and uncertainties with multiple point A's during multiple high-dose-rate intracavitary brachytherapy in carcinoma of the cervix.
Datta NR; Basu R; Das KJ; Rajasekar D; Pandey CM; Singh U; Ayyagari S
Clin Oncol (R Coll Radiol); 2004 Apr; 16(2):129-37. PubMed ID: 15074737
[TBL] [Abstract][Full Text] [Related]
19. Performance assessment of the BEBIG MultiSource high dose rate brachytherapy treatment unit.
Palmer A; Mzenda B
Phys Med Biol; 2009 Dec; 54(24):7417-34. PubMed ID: 19934487
[TBL] [Abstract][Full Text] [Related]
20. Positional and angular tracking of HDR
Aldelaijan S; Devic S; Bekerat H; Papaconstadopoulos P; Schneider J; Seuntjens J; Cormack RA; Buzurovic IM
Med Phys; 2020 Dec; 47(12):6122-6139. PubMed ID: 33064876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]